‘The fact that cancer survival prices were much like surgical interventions is quite encouraging.’ Currently, many patients who are diagnosed with principal tumors that originate inside the kidney are treated surgically. ‘The typical treatment is generally a partial nephrectomy, where the surgeon gets rid of the tumor and some surrounding tissue via open or laparascopic surgery,’ stated Dr. Cadeddu. ‘With surgery, there is a 5 % to 10 % risk of bleeding and an connected need for transfusion, and also an increased chance of readmission for the individual. Of course, the recovery time is as well longer.’ With open medical procedures, surgeons move in through a patient’s abdomen or flank to remove the kidney tumor.Elad Katz is currently functioning as a Senior Scientist for AMS Biotechnology and runs its laboratory facility, located at BioCity Scotland. He regularly advises, collaborates and develops individually solutions for several diseases. This includes understanding the initial tissue microenvironment that is required to build up complex disease models, issues including current imaging and various other techniques and locating the best solution predicated on either existing technologies or combinations of them.